Your browser doesn't support javascript.
Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang, Ying; Wu, Guojun; Zhao, Liping; Wang, Weizheng.
  • Wang Y; Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers, The State University of New Jerseygrid.430387.b, New Brunswick, New Jersey, USA.
  • Wu G; Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers, The State University of New Jerseygrid.430387.b, New Brunswick, New Jersey, USA.
  • Zhao L; Center for Microbiome, Nutrition, and Health, New Jersey Institute for Food, Nutrition, and Health, Rutgers, The State University of New Jerseygrid.430387.b, New Brunswick, New Jersey, USA.
  • Wang W; Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers, The State University of New Jerseygrid.430387.b, New Brunswick, New Jersey, USA.
mBio ; 13(2): e0380121, 2022 04 26.
Article in English | MEDLINE | ID: covidwho-1731259
ABSTRACT
With the increase in total coronavirus disease 2019 (COVID-19) infection cases, post-acute COVID-19 syndrome, defined as experiencing ongoing health problems 4 or more weeks after the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has become a new arising public health concern. As part of post-acute COVID-19 syndrome, gastrointestinal symptoms might be associated with dysbiosis of the gut microbiota, which has the potential to become a target for intervention. In this study, a patient with post-acute COVID-19 syndrome with long-lasting severe gastrointestinal symptoms was provided 2-month expanded access to a high-fiber formula with investigational new drug (IND) status developed to alleviate COVID-19-related symptoms by modulating the gut microbiota. Symptoms including severe "loss of appetite," palpitation, and anxiety were significantly alleviated by the end of the intervention. The medication dosage for controlling nausea decreased during the intervention. The serum lipid profile, insulin level, and leptin level were improved compared to the baseline values. Significant structural changes of the patient's gut microbiota and reduced microbial fermentation activity in the small intestine were found during the intervention. Eighteen amplicon sequence variants (ASVs) of the V4 region of the 16S rRNA gene significantly responded to this nutritional intervention. Six out of the 18 ASVs were also found to be negatively correlated with symptom severity/medication dosage. Five of the six ASVs (ASV0AKS_Oscillibacter, ASV009F_Anaerofustis, ASV02YT_Blautia, ASV07LA_Blautia, and ASV0AM6_Eubacterium hallii) were potential short-chain fatty acid (SCFA)-producing bacteria, which might be associated with the alleviation of symptoms. Our study indicates the feasibility of alleviating gastrointestinal symptoms in patients with post-acute COVID-19 syndrome by way of nutritional modulation of their gut microbiota. IMPORTANCE It has become evident that the care of patients with COVID-19 does not end at the time of negative SARS-CoV-2 detection, as the number of patients with post-acute COVID-19 syndrome increases with an ever-increasing total infected patient population. This case report shows the possibility of alleviating the gastrointestinal symptoms of post-acute COVID-19 syndrome via microbiota-targeted nutritional intervention. As a promising strategy, it might not only improve the quality of life of patients but also reduce the burden to the public health system when the end of the COVID-19 pandemic is not in sight.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Microbiome / Gastrointestinal Diseases / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid / Variants Limits: Humans Language: English Journal: MBio Year: 2022 Document Type: Article Affiliation country: Mbio.03801-21

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Microbiome / Gastrointestinal Diseases / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid / Variants Limits: Humans Language: English Journal: MBio Year: 2022 Document Type: Article Affiliation country: Mbio.03801-21